The Selecting Therapeutic Targets in IBD (STRIDE) update consensus and expert recommendations by the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD), pointed out several targets in ulcerative colitis (UC) and Crohn's disease (CD), the time frames for achieving these targets, and addressed pediatric specific targets.

In the session we would briefly review the IOIBD recommended STRIDE II targets.

Beyond STRIDE II, we will address the concepts of disease clearance in UC, and transmural healing in CD and tools that may contribute to achieving these beyond STRIDE II goals.

As current treatment armamentarium is limited in ability to achieve STRIDE II goals and beyond, we will address strategies, and comprehensive approaches to care.

Specifically-search for new mechanisms of action, addressing fibrosis, using diet in personalized treatment, and multy disciplinary team approach.